Log in Start free →
Today’s CSR movers
PCG 3.7 ▲ 1.5
BMY 3.8 ▲ 0.5
DXCM 4.9 ▲ 0.3
PODD 4.0 ▲ 0.3
LEN 1.8 ▼ 0.3
MGM 3.6 ▼ 0.3
MAS 3.1 ▼ 0.5
PTC 3.1 ▼ 0.6
ES 2.0 ▼ 1.0
CMCSA 2.0 ▼ 1.0
—
—
Health Care · NASDAQ NASDAQ · DXCM

DexCom

$83.39 -$3.37 -4.04% CLOSE 10.06.26 AFTER HOURS $83.40
Convergence score
4.9 / 5.0 STRONG BULLISH
+0.3 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$94.31 +13.1%
Range $75.00 — $115.00
Sector
Health Care
NASDAQ · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 10.06.26
UV Convergence Score
REPORT 10.06.26
4.9
/ 5.0
STRONG BULLISH
Consensus signal A
5.0
Consensus signal B
5.0
Consensus signal D
5.0
Analyst average
4.7
Multi-signal aggregate How CSR works →
Day Range
$82.86 – $86.75
52W Range
$54.11 – $92.59
Volume
3.6M
Avg Vol
4.5M
Mkt Cap
$31.47B
P/E
33.09
EPS (TTM)
$2.52
Div Yield
0.00%
Beta
1.48
Today's convergence

Convergence score sits at 4.9 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
STRONG BULLISH
Last close
$83.39
Sector
Health Care
Valuation
Three horizons
UPDATED 10.06.26
Short term
0–3 MO
No target —
Medium term
3–12 MO
$92+10.3% Buy
Long term
12–36 MO
$51.90-37.8% Overvalued
Open valuation →
Analysts
Coverage & consensus
5 PANELS
Mean target (12mo)
$94.31 +13.1%
RANGE $75.00 — $115.00
Analyst consensus
Consensus rating Buy
Blended score 4.3 / 5
Analysts tracked 139
Open analysts →
Financials
Key metrics
LATEST
P/E
33.09
EPS (TTM)
$2.52
Mkt Cap
$31.47B
Div Yield
0.00%
Beta
1.48
52W Range
$54.11 – $92.59
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 10.06.26
Short term
0–3 MO
—
Consensus target
No target available
Medium term
3–12 MO
Buy
Consensus target
$92 +10.3%
RANGE $75 – $115
$75NOW $83.39$115

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$51.90 -37.8%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Top-level breakdown
Valuation: PE Ratio: 33.09PEG Ratio: -DE Ratio: -
Free Cash Flow: $1.02BPB Ratio: -PS Ratio: -Dividend: -
Analyst coverage

Blended analyst consensus & targets.

5 PANELS · UPDATED 10.06.26
Analyst consensus RATING · SCORE · PANELS · ANALYSTS
Rating Blended score Panels Analysts
Buy 4.3 5 139
Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE
Coverage Low Mean Median High Upside
All panels $75.00 $94.31 $95.00 $115.00 +13.1%
Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL
Coverage SB B H S SS
All panels 5 42 5 0 0
Rating trend CURRENT VS 1M / 2M / 3M
Period Rating Avg Analysts
Current — — —
1 Mo Ago — — —
2 Mo Ago — — —
3 Mo Ago — — —
Most recent analyst action LATEST DESK ACTION
Date
10/1/2026
Firm
Royal Bank Of Canada
Action
Reiterated Rating
Rating
Outperform
Target
$105.00
Related links
Financials

Full financial snapshot.

UPDATED 10.06.26
Quote snapshot 15 FIELDS
Prev Close
$86.90
Open
$86.28
Day Low
$82.86
Day High
$86.75
Bid
$78.20
Ask
$89.55
52W Low
$54.11
52W High
$92.59
50D Avg
$86.68
200D Avg
$73.15
Volume
3.6M
Avg Vol
4.5M
10D Avg Vol
3.3M
52W Change
31.61%
S&P 52W Change
15.78%
Valuation ratios 10 FIELDS
P/E (TTM)
33.09
P/E (Fwd)
26.75
PEG (Fwd)
1.31
P/S
6.33
P/B
12.01
Book Value
$6.95
EV/Revenue
6.49
EV/EBITDA
22.98
Mkt Cap
31.47B
Enterprise Val
32.24B
Profitability & returns 6 FIELDS
Profit Margin
20.12%
Gross Margin
62.47%
Operating Margin
24.33%
EBITDA Margin
28.24%
Return on Assets
10.33%
Return on Equity
38.49%
Growth 3 FIELDS
Revenue Growth (YoY)
13.10%
Earnings Growth (YoY)
43.60%
Earnings Growth (Q)
38.50%
Balance sheet & cash flow 11 FIELDS
Total Revenue
4.97B
EBITDA
1.4B
Total Cash
1.95B
Total Debt
1.4B
Cash / Share
$5.16
Revenue / Share
$12.87
Free Cash Flow
1.02B
Operating CF
1.75B
Debt / Equity
53.35
Current Ratio
1.73
Quick Ratio
1.37
Dividend 5 FIELDS
Fwd Dividend
—
Dividend Yield
0.00%
Payout Ratio
0.00%
5Y Avg Yield
—
Ex-Div Date
—
Share statistics 7 FIELDS
Shares Out
377.36M
Float
376M
Shares Short
17.26M
% Short of Float
5.28%
Short Ratio
4.49
% Held Insiders
0.26%
% Held Institutions
106.63%
Calendar & events 5 FIELDS
Next Earnings
2026-10-29
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-06-30
Last Split
4:1
Split Date
2022-06-13
Company 2 FIELDS
Industry
Medical Devices
Employees
11,000